Pacira Pharmaceuticals, Inc. today announced results from EXCLAIM, its Phase 4 prospective, observational study to assess the use of EXPARELA for postsurgical analgesia in patients undergoing four common plastic surgery procedures.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130412005036&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130412005036&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment